CymaBay Therapeutics Inc. (CBAY) SEC filings
CBAY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CBAY overview →
13 measured CBAY SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G CymaBay Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT CymaBay Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K CymaBay Therapeutics, For: Mar 22 | SEC filing · Form 8-K | — | — | |
| Form POS AM CymaBay Therapeutics, | SEC filing · Form POS | — | — | |
| Form POSASR CymaBay Therapeutics, | SEC filing · Form POSASR | — | — | |
| Form S-8 POS CymaBay Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K CymaBay Therapeutics, For: Mar 18 | SEC filing · Form 8-K | +0.00% | -0.03% | |
| Form 10-K CymaBay Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.15% | -0.28% | |
| Form 8-K CymaBay Therapeutics, For: Feb 11 | SEC filing · Form 8-K | +0.02% | +0.81% | |
| Form 8-K CymaBay Therapeutics, For: Jan 24 | SEC filing · Form 8-K | -0.19% | +3.44% | |
| Form 8-K CymaBay Therapeutics, For: Dec 19 | SEC filing · Form 8-K | +0.36% | +3.64% | |
| Form 8-K CymaBay Therapeutics, For: Dec 11 | SEC filing · Form 8-K | -2.13% | -0.87% | |
| Form 10-Q CymaBay Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.80% | -4.27% |
Keep exploring
More CBAY: earnings → · analyst actions → · CBAY overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | 167 | -0.32% | 42% |
| Boundless Bio, Inc. (BOLD) | 166 | -0.48% | 44% |
| Innoviva, Inc. (INVA) | 166 | +0.10% | 54% |
| MediWound Ltd. - Ordinary Shares (MDWD) | 166 | +0.11% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.